VIRX
Viracta Therapeutics Inc
Price:  
0.08 
USD
Volume:  
9,368,752.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

VIRX WACC - Weighted Average Cost of Capital

The WACC of Viracta Therapeutics Inc (VIRX) is 5.0%.

The Cost of Equity of Viracta Therapeutics Inc (VIRX) is 37.55%.
The Cost of Debt of Viracta Therapeutics Inc (VIRX) is 5.00%.

Range Selected
Cost of equity 31.00% - 44.10% 37.55%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 4.8% - 5.2% 5.0%
WACC

VIRX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 5.89 7.01
Additional risk adjustments 0.0% 0.5%
Cost of equity 31.00% 44.10%
Tax rate 26.20% 27.00%
Debt/Equity ratio 24.46 24.46
Cost of debt 5.00% 5.00%
After-tax WACC 4.8% 5.2%
Selected WACC 5.0%